
Biotechnology • Pharmaceuticals • Healthcare Insurance
Apellis Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic treatments targeting the complement system. The company is dedicated to transforming the treatment landscape for debilitating diseases, with a particular focus on ophthalmology and rare diseases. Apellis is committed to advancing complement science to address unmet medical needs through its robust pipeline of clinical trials and approved products. With a keen emphasis on patient-centered approaches and community engagement, Apellis strives to deliver breakthrough therapies to improve patient outcomes.
501 - 1000 employees
Founded 2009
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
October 29
Sr. Director of Clinical Science at Apellis, leading clinical programs and multidisciplinary teams for innovative biopharmaceutical therapies. Overseeing clinical strategy and execution in a remote setting.